To further investigate the functional impact of these mutations, the expression of CCND1, a downstream target of the Wnt/β‐catenin pathway, was analyzed in HCC tissues with elevated β‐catenin levels. This evidence concerns the gene CCND1 and hepatocellular carcinoma.